<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or <break/>reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Strain, strain background (<italic>Escherichia coli</italic>)</td><td>BL21 (DE3)</td><td>EMBL protein expression facility</td><td>NA</td><td/></tr><tr><td>Strain, strain background (<italic>Escherichia coli</italic>)</td><td>BL21 Rosetta 2</td><td>Merck Millipore</td><td>Cat #71400&#8211;3</td><td/></tr><tr><td>Recombinant DNA reagent</td><td>pETM-11 Fibrillarin (plasmid)</td><td><xref ref-type="bibr" rid="bib27">Lapinaite et al. (2013)</xref></td><td/><td>Nterminal His6 + TEV site</td></tr><tr><td>Recombinant DNA reagent</td><td>pETM-11 Nop5 (plasmid)</td><td><xref ref-type="bibr" rid="bib27">Lapinaite et al. (2013)</xref></td><td/><td>Nterminal His6 + TEV site; L113K V223E mutant. Codon-optimised synthetic gene (GeneArt)</td></tr><tr><td>Recombinant DNA reagent</td><td>pETM-11 Nop5 E65C (plasmid)</td><td><xref ref-type="bibr" rid="bib27">Lapinaite et al. (2013)</xref></td><td/><td>Mutation of pETM-11 Nop5</td></tr><tr><td>Recombinant DNA reagent</td><td>pETM-11 Nop5 E196C (plasmid)</td><td><xref ref-type="bibr" rid="bib27">Lapinaite et al. (2013)</xref></td><td/><td>Mutation of pETM-11 Nop5</td></tr><tr><td>Recombinant DNA reagent</td><td>pETM-11 Nop5 D247C (plasmid)</td><td><xref ref-type="bibr" rid="bib27">Lapinaite et al. (2013)</xref></td><td/><td>Mutation of pETM-11 Nop5</td></tr><tr><td>Recombinant DNA reagent</td><td>pETM-11 Nop5 S343C (plasmid)</td><td><xref ref-type="bibr" rid="bib27">Lapinaite et al. (2013)</xref></td><td/><td>Mutation of pETM-11 Nop5</td></tr><tr><td>Recombinant DNA reagent</td><td>pETM-11 L7Ae (plasmid)</td><td><xref ref-type="bibr" rid="bib27">Lapinaite et al. (2013)</xref></td><td/><td>Nterminal His6 + TEV site</td></tr><tr><td>Recombinant DNA reagent</td><td>pETM-11 L7Ae Q45C (plasmid)</td><td><xref ref-type="bibr" rid="bib27">Lapinaite et al. (2013)</xref></td><td/><td>Mutation of pETM-11 L7Ae also carrying C68S mutation</td></tr><tr><td>Recombinant DNA reagent</td><td>pETM-11 L7Ae E58C (plasmid)</td><td><xref ref-type="bibr" rid="bib27">Lapinaite et al. (2013)</xref></td><td/><td>Mutation of pETM-11 L7Ae also carrying C68S mutation</td></tr><tr><td>Sequence-based reagent</td><td>st-sR26</td><td><xref ref-type="bibr" rid="bib16">Graziadei et al. (2016)</xref></td><td>In vitro transcribed RNA</td><td/></tr><tr><td>Sequence-based reagent</td><td>st-sR26-1</td><td>This paper</td><td>In vitro transcribed RNA</td><td>Method section: RNA synthesis</td></tr><tr><td>Sequence-based reagent</td><td>st-sR26-1 substrate</td><td>This paper</td><td>In vitro transcribed RNA</td><td>Method section: RNA synthesis</td></tr><tr><td>Sequence-based reagent</td><td>st-sR26-1 A61C</td><td>This paper</td><td>In vitro transcribed RNA</td><td>Method section: RNA synthesis</td></tr><tr><td>Sequence-based reagent</td><td>st-sR26-1 A61U</td><td>This paper</td><td>In vitro transcribed RNA</td><td>Method section: RNA synthesis</td></tr><tr><td>Sequence-based reagent</td><td>st-sR26-2</td><td>This paper</td><td>In vitro transcribed RNA</td><td>Method section: RNA synthesis</td></tr><tr><td>Sequence-based reagent</td><td>st-sR26-2 substrate</td><td>This paper</td><td>In vitro transcribed RNA</td><td>Method section: RNA synthesis</td></tr><tr><td>Sequence-based reagent</td><td>sR26</td><td><xref ref-type="bibr" rid="bib16">Graziadei et al. (2016)</xref></td><td>In vitro transcribed RNA</td><td/></tr><tr><td>Sequence-based reagent</td><td>ssR26</td><td><xref ref-type="bibr" rid="bib27">Lapinaite et al. (2013)</xref></td><td>In vitro transcribed RNA</td><td/></tr><tr><td>Commercial assay or kit</td><td>TLAM-ILVproS labelling</td><td>NMR-Bio</td><td>NA</td><td/></tr><tr><td>Chemical compound, drug</td><td>Iodoacetoamido-PROXYL</td><td>Sigma-Aldrich</td><td>Cat # 253421&#8211;25 MG</td><td/></tr><tr><td>Chemical compound, drug</td><td>(methyl-13C, 99%; 3,3-D2, 98%) &#945;-ketobutyric acid</td><td>Cambridge Isotope Labs</td><td>CDLM-7318-PK</td><td/></tr><tr><td>Chemical compound, drug</td><td>(3-methyl-13C, 99%; 3,4,4,4-D4, 98%) &#945;-ketoisovaleric acid</td><td>Cambridge Isotope Labs</td><td>CDLM-7317-PK</td><td/></tr><tr><td>Chemical compound, drug</td><td>[3&#8211;2 H2,4&#8211;2H, 5&#8211;13C, 5&#8217;&#8722;2 H3]-a-ketoiso-caproate</td><td><xref ref-type="bibr" rid="bib28">Lichtenecker et al. (2013)</xref></td><td/><td/></tr><tr><td>Software, algorithm</td><td>CNS</td><td>This paper</td><td/><td>Method section: Structure calculation and selection. Adaptation of protocol from <xref ref-type="bibr" rid="bib27">Lapinaite et al. (2013)</xref></td></tr><tr><td>Software, algorithm</td><td>Python-based SAS-PRE scoring algorithm</td><td>This paper</td><td/><td/></tr><tr><td>Software, algorithm</td><td>ATSAS 2.7.5</td><td><xref ref-type="bibr" rid="bib36">Petoukhov et al., 2012</xref></td><td/><td/></tr><tr><td>Software, algorithm</td><td>Python-based SAS-PRE scoring algorithm</td><td>This paper</td><td/><td>Method section: Ensemble Scoring</td></tr></tbody></table></table-wrap>